Ohio provider first double winner of HIMSS Davies Award

The Ohio State’s Wexner Medical Center (OSUWMC) is the first two-time winner of the HIMSS Davies Award. Since 1994, the HIMSS Nicholas E. Davies Award of Excellence has recognized outstanding achievement of organizations that have utilized health IT to substantially improve patient outcomes while achieving return on investment. It also promotes EHR-enabled improvement in patient outcomes through sharing of case studies and lessons learned across a wide range of efforts. 

OSUWMC first won Davies Award Recognition in 2001. The facility serves all patients and populations, with the uninsured and Medicaid population comprising approximately 25 percent of the organization’s patient mix. OSUWMC has a staff of approximately 16,000, with over 1,500 physicians, 900 fellows/residents and 500 mid-level providers.

OSUWMC has launched a clinical data mart designed to monitor the use of anti-microbial medication. Through the utilization of policies developed as result of analysis of data from the data mart, it significantly reduced the use of IV ciprofloxacin and a corresponding reduction of C. difficile infection rates. Using health maintenance alerts and standardized care, OSUWMC has significantly improved chronic disease management, including a 5 percent increase in the number of diabetic patients with HgbA1c under control.

In addition, the OSUWMC IT department implemented a facility charge calculator within the EMR to more accurately code levels of service based on chart documentation in the emergency department. With the implementation of the charge calculator, OSUWMC has realized approximately $50 million in gross revenue per year from charges that would have been otherwise missed under the old system.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.